المؤلفون: Cooke SA; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Belderbos JSA; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands. Electronic address: J.belderbos@nki.nl., Reymen B; Department of Radiation Oncology (MAASTRO Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Lambrecht M; Department of Oncology, Experimental Radiation Oncology, KU Leuven - University of Leuven, Leuven, Belgium; Department of Radiotherapy-Oncology, University Hospitals Leuven, Gasthuisberg, Belgium., Fredberg Persson G; Department of Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Faivre-Finn C; Department of Clinical Oncology, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK., Dieleman EMT; Department of Radiation Oncology, Location AMC, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., van Diessen JNA; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Sonke JJ; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., de Ruysscher D; Department of Radiation Oncology (MAASTRO Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jul; Vol. 196, pp. 110312. Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/radiotherapy , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Patient Reported Outcome Measures* , Quality of Life*, Humans ; Male ; Female ; Middle Aged ; Aged ; Neoplasm Staging ; Radiotherapy Dosage ; Chemoradiotherapy/adverse effects ; Positron-Emission Tomography

المؤلفون: Nakamura R; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Yamada T; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Electronic address: tayamada@koto.kpu-m.ac.jp., Tokuda S; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Morimoto K; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Katayama Y; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Matsui Y; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Hirai S; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Ishida M; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Kawachi H; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Sawada R; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Tachibana Y; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Osoegawa A; Department of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Oita, Japan., Horinaka M; Department of Drug Discovery Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Sakai T; Department of Drug Discovery Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Yasuhiro T; Research Center of Oncology, Discovery and Research, Ono Pharmaceutical Co., Ltd., Osaka, Japan., Kozaki R; Research Center of Oncology, Discovery and Research, Ono Pharmaceutical Co., Ltd., Osaka, Japan., Yano S; Department of Respiratory Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan; WPI-Nano Life Science Institute (WPI-Nano LSI), Kanazawa University, Kanazawa, Japan., Takayama K; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

المصدر: Cancer letters [Cancer Lett] 2024 Aug 28; Vol. 598, pp. 217124. Date of Electronic Publication: 2024 Jul 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

مواضيع طبية MeSH: Acrylamides*/pharmacology , Aniline Compounds*/pharmacology , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Axl Receptor Tyrosine Kinase* , ErbB Receptors*/antagonists & inhibitors , ErbB Receptors*/genetics , Proto-Oncogene Proteins*/genetics , Proto-Oncogene Proteins*/antagonists & inhibitors , Proto-Oncogene Proteins*/metabolism , Receptor, Fibroblast Growth Factor, Type 1*/antagonists & inhibitors , Receptor, Fibroblast Growth Factor, Type 1*/genetics , Receptor, Fibroblast Growth Factor, Type 1*/metabolism , Receptor Protein-Tyrosine Kinases*/antagonists & inhibitors , Receptor Protein-Tyrosine Kinases*/genetics , Antineoplastic Combined Chemotherapy Protocols*/pharmacology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Xenograft Model Antitumor Assays* , Mutation* , Pyrimidines*/pharmacology, Humans ; Animals ; Cell Line, Tumor ; Mice, Nude ; Protein Kinase Inhibitors/pharmacology ; Drug Resistance, Neoplasm/drug effects ; Mice ; Apoptosis/drug effects ; Phenylurea Compounds/pharmacology ; Phenylurea Compounds/administration & dosage ; Female ; Mice, Inbred BALB C ; Cell Survival/drug effects ; Piperazines/pharmacology ; Benzocycloheptenes ; Indoles ; Triazoles

المؤلفون: Xu Z; Department of Respiratory and Critical Care Medicine, Center for Oncology Medical, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China; Zhejiang Key Laboratory of Precision Diagnosis and Treatment for Lung Cancer, Yiwu, 322000, China., Shi Y; Department of Respiratory and Critical Care Medicine, Center for Oncology Medical, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China; Zhejiang Key Laboratory of Precision Diagnosis and Treatment for Lung Cancer, Yiwu, 322000, China., Zhu L; Department of Rheumatology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, Zhejiang, China., Luo J; Department of Respiratory and Critical Care Medicine, Center for Oncology Medical, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China; Zhejiang Key Laboratory of Precision Diagnosis and Treatment for Lung Cancer, Yiwu, 322000, China; Department of Respiratory Medicine, Taizhou Municipal Hospital, Taizhou, 318000, Zhejiang, China., Hu Q; Department of Respiratory and Critical Care Medicine, Center for Oncology Medical, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China; Zhejiang Key Laboratory of Precision Diagnosis and Treatment for Lung Cancer, Yiwu, 322000, China., Jiang S; Department of Respiratory and Critical Care Medicine, Center for Oncology Medical, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China; Zhejiang Key Laboratory of Precision Diagnosis and Treatment for Lung Cancer, Yiwu, 322000, China., Xiao M; Department of Respiratory and Critical Care Medicine, Center for Oncology Medical, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China; Zhejiang Key Laboratory of Precision Diagnosis and Treatment for Lung Cancer, Yiwu, 322000, China., Jiang X; Department of Respiratory and Critical Care Medicine, Center for Oncology Medical, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China; Zhejiang Key Laboratory of Precision Diagnosis and Treatment for Lung Cancer, Yiwu, 322000, China., Wang H; Department of Respiratory and Critical Care Medicine, Center for Oncology Medical, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China; Zhejiang Key Laboratory of Precision Diagnosis and Treatment for Lung Cancer, Yiwu, 322000, China., Xu Y; Department of Respiratory and Critical Care Medicine, Center for Oncology Medical, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China; Zhejiang Key Laboratory of Precision Diagnosis and Treatment for Lung Cancer, Yiwu, 322000, China., Jin W; Department of Respiratory and Critical Care Medicine, Center for Oncology Medical, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China., Zhou Y; Department of Respiratory and Critical Care Medicine, Center for Oncology Medical, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China; Zhejiang Key Laboratory of Precision Diagnosis and Treatment for Lung Cancer, Yiwu, 322000, China., Wang P; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, Zhejiang, China., Wang K; Department of Respiratory and Critical Care Medicine, Center for Oncology Medical, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China; Zhejiang Key Laboratory of Precision Diagnosis and Treatment for Lung Cancer, Yiwu, 322000, China. Electronic address: Kaiw@zju.edu.cn.

المصدر: Cancer letters [Cancer Lett] 2024 Aug 28; Vol. 598, pp. 217075. Date of Electronic Publication: 2024 Jun 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoplasmic Reticulum Calcium-Transporting ATPases*/metabolism , Sarcoplasmic Reticulum Calcium-Transporting ATPases*/antagonists & inhibitors , Endoplasmic Reticulum Stress*/drug effects , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/metabolism , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/metabolism , Mitochondria*/drug effects , Mitochondria*/metabolism , Apoptosis*/drug effects , Cell Proliferation*/drug effects , Xenograft Model Antitumor Assays*, Humans ; Animals ; Mice ; Membrane Potential, Mitochondrial/drug effects ; Reactive Oxygen Species/metabolism ; Cell Line, Tumor ; Calcium/metabolism ; A549 Cells ; Drug Synergism ; Mice, Nude ; Antineoplastic Agents/pharmacology ; Cell Movement/drug effects ; Cisplatin/pharmacology ; Mice, Inbred BALB C ; Calcium Signaling/drug effects ; Endoplasmic Reticulum/drug effects ; Endoplasmic Reticulum/metabolism

المؤلفون: Liu X; Department of Pathology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, ShaanXi, China., Guo R; Department of Pathology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, ShaanXi, China., Li D; Department of Pathology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, ShaanXi, China., Wang Y; Department of Pathology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, ShaanXi, China., Ning J; Department of Respiratory Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, ShaanXi, China., Yang S; Department of Respiratory Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, ShaanXi, China. yangshuanying@xjtu.edu.cn., Yang J; Department of Pathology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, ShaanXi, China. yangjundr@163.com.

المصدر: Scientific reports [Sci Rep] 2024 Aug 15; Vol. 14 (1), pp. 18952. Date of Electronic Publication: 2024 Aug 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/mortality , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality , Neoplasm Invasiveness*, Humans ; Male ; Female ; Middle Aged ; Prognosis ; Aged ; Kaplan-Meier Estimate ; Adult ; Disease-Free Survival ; Neoplasm Staging ; Biomarkers, Tumor/metabolism

المؤلفون: Desai A; Department of Medicine, University of Alabama, Birmingham, Alabama, USA., Smith CJ; Mayo Clinic, Rochester, Minnesota, USA., Pritchett JC; Mayo Clinic, Rochester, Minnesota, USA., Leventakos K; Mayo Clinic, Rochester, Minnesota, USA., West HJ; Summit Therapeutics, PLC, Menlo Park, California, USA.

المصدر: Cancer [Cancer] 2024 Aug 15; Vol. 130 (16), pp. 2807-2811. Date of Electronic Publication: 2024 Feb 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/immunology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/immunology , Lung Neoplasms*/mortality , Immunotherapy*/methods , Immune Checkpoint Inhibitors*/therapeutic use , Cross-Over Studies*, Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Clinical Trials, Phase III as Topic

المؤلفون: Huang S; Cancer center, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, China., Zhang J; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education, Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, China., Wu X; Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China., Liang B; The School of Food Science and Biology, Guangdong Polytechnic of Science and Trade, Guangzhou, China., Pang N; Department of Nutrition; Guangdong Provincial Key Laboratory of Food, Nutrition and Health; School of Public Health, Sun Yat-Sen University, Guangzhou, China., Yang L; Department of Nutrition; Guangdong Provincial Key Laboratory of Food, Nutrition and Health; School of Public Health, Sun Yat-Sen University, Guangzhou, China. Electronic address: yangll7@mail.sysu.edu.cn., Zhang Z; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education, Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. Electronic address: zhangzhf@gzhmu.edu.cn.

المصدر: Life sciences [Life Sci] 2024 Aug 15; Vol. 351, pp. 122849. Date of Electronic Publication: 2024 Jun 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0631 (Electronic) Linking ISSN: 00243205 NLM ISO Abbreviation: Life Sci Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/metabolism , Erlotinib Hydrochloride*/pharmacology , Erlotinib Hydrochloride*/therapeutic use , Axl Receptor Tyrosine Kinase* , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Lung Neoplasms*/metabolism , Proto-Oncogene Proteins*/genetics , Proto-Oncogene Proteins*/metabolism , Receptor Protein-Tyrosine Kinases*/genetics , Receptor Protein-Tyrosine Kinases*/metabolism , Drug Resistance, Neoplasm*/genetics, Humans ; Gene Expression Regulation, Neoplastic/drug effects ; Cell Proliferation/drug effects ; Cell Line, Tumor ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Epithelial-Mesenchymal Transition/drug effects ; Epithelial-Mesenchymal Transition/genetics ; Animals ; Mice

المؤلفون: Wu W; Department of Intergrated Therapy in Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, No. 651, East Dong Feng Road, Guangzhou, Guangdong, 510060, China.; Zhongshan School of Medicine, Sun Yat-Sen University, No. 74, Zhong Shan Er Lu, Guangzhou, Guangdong, 510060, China., Yu S; Department of Intergrated Therapy in Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, No. 651, East Dong Feng Road, Guangzhou, Guangdong, 510060, China.; Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510060, China., Huang J; Department of Intergrated Therapy in Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, No. 651, East Dong Feng Road, Guangzhou, Guangdong, 510060, China., Qi Q; Department of Intergrated Therapy in Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, No. 651, East Dong Feng Road, Guangzhou, Guangdong, 510060, China.; Zhongshan School of Medicine, Sun Yat-Sen University, No. 74, Zhong Shan Er Lu, Guangzhou, Guangdong, 510060, China., Wu Y; Department of Intergrated Therapy in Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, No. 651, East Dong Feng Road, Guangzhou, Guangdong, 510060, China.; Zhongshan School of Medicine, Sun Yat-Sen University, No. 74, Zhong Shan Er Lu, Guangzhou, Guangdong, 510060, China., Dong J; Department of Intergrated Therapy in Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, No. 651, East Dong Feng Road, Guangzhou, Guangdong, 510060, China. dongjun1@sysucc.org.cn.

المصدر: BMC cancer [BMC Cancer] 2024 Aug 14; Vol. 24 (1), pp. 1010. Date of Electronic Publication: 2024 Aug 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , ErbB Receptors*/genetics , Lung Neoplasms*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Exons*, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; China ; Treatment Outcome ; Adult ; Pemetrexed/therapeutic use ; Pemetrexed/administration & dosage ; Protein Kinase Inhibitors/therapeutic use ; Mutagenesis, Insertional ; Mutation ; Aged, 80 and over ; East Asian People

المؤلفون: Tane K; Division of Thoracic Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan., Shiono S; Department of Surgery II, Faculty of Medicine, 2-2-2 Iida-Nishi, Yamagatashi, Yamagata 990-9585, Japan., Wakabayashi M; JCOG Data Center/Operations Office, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuoku, Tokyo, 104-0045, Japan., Kataoka T; JCOG Data Center/Operations Office, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuoku, Tokyo, 104-0045, Japan., Mitome N; JCOG Data Center/Operations Office, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuoku, Tokyo, 104-0045, Japan., Fukuda H; JCOG Data Center/Operations Office, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuoku, Tokyo, 104-0045, Japan., Aokage K; Division of Thoracic Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan., Watanabe SI; Division of Thoracic Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuoku, Tokyo, 104-0045, Japan.

مؤلفون مشاركون: In behalf of the Lung Cancer Surgical Study Group/Japan Clinical Oncology Group

المصدر: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 Aug 14; Vol. 54 (8), pp. 926-929.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Clinical Trial Protocol; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/surgery , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/pathology , Lung Neoplasms*/surgery , Lung Neoplasms*/diagnostic imaging , Neoplasm Staging*, Humans ; Male ; Female ; Tomography, X-Ray Computed ; Neoplasm Recurrence, Local/pathology ; Middle Aged ; Aged ; Pneumonectomy ; Adult ; Japan/epidemiology

المؤلفون: Iwata K; Department of General Thoracic Surgery and Brest and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan., Suzawa K; Department of General Thoracic Surgery and Brest and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.; Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan., Hashimoto K; Department of General Thoracic Surgery and Brest and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.; Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan., Tanaka S; Department of General Thoracic Surgery and Brest and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.; Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan., Shien K; Department of General Thoracic Surgery and Brest and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.; Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan., Miyoshi K; Department of General Thoracic Surgery and Brest and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.; Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan., Yamamoto H; Department of General Thoracic Surgery and Brest and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.; Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan., Okazaki M; Department of General Thoracic Surgery and Brest and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.; Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan., Sugimoto S; Department of General Thoracic Surgery and Brest and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.; Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan., Toyooka S; Department of General Thoracic Surgery and Brest and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.; Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.

المصدر: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 Aug 14; Vol. 54 (8), pp. 895-902.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/immunology , Carcinoma, Non-Small-Cell Lung*/surgery , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/blood , Carcinoma, Non-Small-Cell Lung*/mortality , Neutrophils* , Lung Neoplasms*/immunology , Lung Neoplasms*/surgery , Lung Neoplasms*/pathology , Lung Neoplasms*/blood , Lung Neoplasms*/mortality , Lymphocytes, Tumor-Infiltrating*/immunology, Humans ; Male ; Female ; Retrospective Studies ; Aged ; Middle Aged ; Prognosis ; Lymphocytes/immunology ; Aged, 80 and over ; Adult ; Biomarkers, Tumor/blood ; Lymphocyte Count

المؤلفون: Andersen MB; Department of Radiology, Copenhagen University Hospital, Gentofte, Denmark. Michael.brun.andersen@regionh.dk.; Department of Radiology, Zealand University Hospital, Køge, Denmark. Michael.brun.andersen@regionh.dk.; Department of Radiology, Aarhus University Hospital, Skejby, Denmark. Michael.brun.andersen@regionh.dk.; Radiology Department, Copenhagen University Hospital, Gentofte Hospitalsvej 1, 2900, Hellerup, Denmark. Michael.brun.andersen@regionh.dk.; Department of clinical medicine, Copenhagen University, Copenhagen, Denmark. Michael.brun.andersen@regionh.dk., Drljevic-Nielsen A; Department of Radiology and Oncology, Aarhus University Hospital, Skejby, Denmark., Ehlers JH; Department of Oncology, Zealand University Hospital, Køge, Denmark., Thorup KS; Department of Radiology, Aarhus University Hospital, Skejby, Denmark., Baandrup AO; Department of Radiology, Zealand University Hospital, Køge, Denmark., Palne M; Department of Radiology, Zealand University Hospital, Køge, Denmark., Rasmussen F; Department of Radiology, Aarhus University Hospital, Skejby, Denmark.

المصدر: Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2024 Aug 13; Vol. 24 (1), pp. 105. Date of Electronic Publication: 2024 Aug 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Nature Country of Publication: England NLM ID: 101172931 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-7330 (Electronic) Linking ISSN: 14707330 NLM ISO Abbreviation: Cancer Imaging Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/drug therapy , Lung Neoplasms*/diagnostic imaging , Immune Checkpoint Inhibitors*/therapeutic use , Feasibility Studies* , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/diagnostic imaging , Tomography, X-Ray Computed*/methods, Humans ; Male ; Female ; Aged ; Middle Aged ; Prospective Studies ; Contrast Media ; Prognosis ; Aged, 80 and over